US FDA Converges With Other Regulators On Insomnia Drug Warnings, But Broader Safety Disagreements Persist

 
• By Michael Cipriano
  
Moon
A set of insomnia drugs will come with more restrictive labeling.

More from Drug Safety

More from Pink Sheet